MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 93 filers reported holding MYOVANT SCIENCES LTD in Q2 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $303,327 | -25.7% | 11,251 | -50.4% | 0.16% | -3.1% |
| Q3 2022 | $408,000 | +46.8% | 22,690 | +1.5% | 0.16% | +58.3% |
| Q2 2022 | $278,000 | +95.8% | 22,356 | +109.8% | 0.10% | +60.9% |
| Q1 2022 | $142,000 | -19.3% | 10,655 | -5.6% | 0.06% | -3.0% |
| Q4 2021 | $176,000 | -19.6% | 11,289 | +15.7% | 0.07% | -31.2% |
| Q3 2021 | $219,000 | -6.4% | 9,755 | -5.0% | 0.10% | 0.0% |
| Q2 2021 | $234,000 | -8.6% | 10,270 | -17.6% | 0.10% | -11.1% |
| Q1 2021 | $256,000 | -24.3% | 12,457 | +1.8% | 0.11% | -22.9% |
| Q4 2020 | $338,000 | +31.5% | 12,236 | -33.2% | 0.14% | +3.7% |
| Q3 2020 | $257,000 | -40.1% | 18,324 | -12.0% | 0.14% | -33.5% |
| Q2 2020 | $429,000 | +138.3% | 20,817 | -12.9% | 0.20% | +174.3% |
| Q1 2020 | $180,000 | -57.6% | 23,895 | -12.7% | 0.07% | +7.2% |
| Q4 2019 | $425,000 | +179.6% | 27,369 | -6.2% | 0.07% | +122.6% |
| Q3 2019 | $152,000 | -45.5% | 29,180 | -5.3% | 0.03% | -47.5% |
| Q2 2019 | $279,000 | – | 30,799 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 85,000 | $1,132,000 | 1.20% |
| Bellevue Group AG | 5,859,039 | $78,042,000 | 0.91% |
| APIS CAPITAL ADVISORS, LLC | 40,000 | $533,000 | 0.64% |
| Pier Capital, LLC | 294,954 | $3,929,000 | 0.50% |
| Resolute Capital Asset Partners LLC | 50,000 | $666,000 | 0.42% |
| Rhenman & Partners Asset Management AB | 249,300 | $3,321,000 | 0.33% |
| Hennion & Walsh Asset Management, Inc. | 409,079 | $5,449,000 | 0.29% |
| TORRAY INVESTMENT PARTNERS LLC | 79,868 | $1,064,000 | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 195,211 | $2,600,000 | 0.08% |
| DUALITY ADVISERS, LP | 54,164 | $721,000 | 0.08% |